IGF1 and thyroid cancer, nonmedullary, 2: In FTC tissue, miR-29b-3p levels are elevated because of H19 under expression, and IGF2BP1 levels are consequently reduced, causing the pathological increase in IGF1 expression, driving FTC carcinogenesis [106].